Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Campbell

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Trials|March 2, 2021
UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysisMatthew Burnell, Aleksandra Gentry-Maharaj, Steven J Skates, et al.
Ebiomedicine|January 14, 2025
Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCSJacob S Bedia, Ian J Jacobs, Andy Ryan, et al.
Gynecologic Oncology|November 19, 2023
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)James Dilley, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Journal of Global Health|December 19, 2015
Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysisTing Shi, Evelyn Balsells, Elizabeth Wastnedge, et al.
Gynecologic Oncology|June 21, 2020
Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)James Dilley, Matthew Burnell, Aleksandra Gentry-Maharaj, et al.
Trials|January 26, 2021
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplarJatinderpal K Kalsi, Andy Ryan, Aleksandra Gentry-Maharaj, et al.
Cancers|March 6, 2021
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
The Lancet. Oncology|September 1, 2023
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Cell Stem Cell|January 21, 2020
Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCsJiesi Luo, Lingfeng Qin, Liping Zhao, et al.
Biomaterials|September 25, 2017
Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineeringJiesi Luo, Lingfeng Qin, Mehmet H Kural, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Trials|March 2, 2021
UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysisMatthew Burnell, Aleksandra Gentry-Maharaj, Steven J Skates, et al.
Ebiomedicine|January 14, 2025
Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCSJacob S Bedia, Ian J Jacobs, Andy Ryan, et al.
Gynecologic Oncology|November 19, 2023
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)James Dilley, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Journal of Global Health|December 19, 2015
Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysisTing Shi, Evelyn Balsells, Elizabeth Wastnedge, et al.
Gynecologic Oncology|June 21, 2020
Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)James Dilley, Matthew Burnell, Aleksandra Gentry-Maharaj, et al.
Trials|January 26, 2021
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplarJatinderpal K Kalsi, Andy Ryan, Aleksandra Gentry-Maharaj, et al.
Cancers|March 6, 2021
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
The Lancet. Oncology|September 1, 2023
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Cell Stem Cell|January 21, 2020
Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCsJiesi Luo, Lingfeng Qin, Liping Zhao, et al.
Biomaterials|September 25, 2017
Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineeringJiesi Luo, Lingfeng Qin, Mehmet H Kural, et al.
Pageof 11